New Vaccines for Epizootic Hemorrhagic Disease Virus
Author Information
Author(s): Jiménez-Cabello Luis, Utrilla-Trigo Sergio, Rodríguez-Sabando Karen, Carra-Valenzuela Alejandro, Illescas-Amo Miguel, Calvo-Pinilla Eva, Ortego Javier
Primary Institution: Centro de Investigación en Sanidad Animal (CISA), Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Valdeolmos, Madrid, Spain
Hypothesis
Can modified vaccinia virus Ankara (MVA)-vectored vaccines expressing VP2 or VP7 provide protection against Epizootic hemorrhagic disease virus (EHDV) in mice?
Conclusion
The MVA-VP2 and MVA-VP7 vaccine candidates conferred full protection against EHDV-8 and EHDV-6 in mice, with MVA-VP7 showing multiserotype protection.
Supporting Evidence
- Immunization with MVA-VP2 induced high titers of EHDV-8-specific neutralizing antibodies.
- Mice immunized with MVA-VP7 showed complete protection against lethal challenge with EHDV-6.
- Both vaccine candidates were able to induce a strong immune response in the mouse model.
Takeaway
Scientists created new vaccines to protect mice from a virus that makes animals sick, and they found that one of the vaccines works against different types of the virus.
Methodology
The study involved immunizing IFNAR(−/−) mice with MVA-VP2 or MVA-VP7 and then challenging them with lethal doses of EHDV-8 or EHDV-6 to assess protection.
Limitations
The study was conducted in a mouse model, which may not fully replicate responses in natural hosts.
Participant Demographics
Adult IFNAR(−/−) mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website